Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder

This study assessed prevention of relapse in patients with treatment-resistant depression (TRD) taking olanzapine/fluoxetine combination (OFC). Patients with major depressive disorder (MDD) who failed to satisfactorily respond to ⩾2 different antidepressants for ⩾6 weeks within the current MDD episo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Brunner, Elizabeth, Tohen, Mauricio, Osuntokun, Olawale, Landry, John, Thase, Michael E
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207330/
https://ncbi.nlm.nih.gov/pubmed/24801768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2014.101
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars